This segment focuses on the collection, processing, and long-term storage of umbilical cord blood stem cells. PBKM utilizes advanced cryopreservation techniques to ensure the viability of stem cells for potential future medical applications. Research and development activities include improving storage methods and exploring new therapeutic uses of cord blood stem cells. The company's diagnostic services and research collaborations support this segment. Patient impact is significant, as stored stem cells can be used to treat various diseases, including blood disorders and certain cancers. PBKM's market positioning is strong in Poland and expanding internationally, with a focus on providing high-quality services and adhering to stringent regulatory standards. Future opportunities include expanding into new therapeutic areas and developing advanced cell-based therapies. Regulatory compliance with international standards and partnerships with medical institutions are crucial for this segment's success.

This segment involves the collection, processing, and storage of other afterbirth tissues, such as the umbilical cord and placenta. Research and development efforts focus on isolating and characterizing stem cells from these tissues, exploring their potential in regenerative medicine. Technologies used include cell culture, flow cytometry, and molecular biology techniques. Therapeutic areas include wound healing, tissue repair, and potentially treating neurological disorders. The patient impact lies in providing access to stem cells for various medical conditions. PBKM aims to expand its market presence by offering comprehensive tissue banking services. Future opportunities include developing advanced therapies based on these tissues and expanding into new markets. Regulatory compliance and clinical trials are essential for validating the safety and efficacy of these therapies. Partnerships with hospitals and research institutions are key to advancing this segment.

This segment encompasses research and development activities focused on stem cell applications, diagnostic services, and the development of new therapies. PBKM conducts research on mesenchymal stem cells (MSCs) and their potential in treating various diseases. The company utilizes advanced technologies such as gene expression analysis and cell-based assays. Therapeutic areas include autism, Alzheimer's disease, and other conditions where stem cell therapy may be beneficial. The patient impact is significant, as these research efforts aim to develop new treatments and improve patient outcomes. PBKM's market positioning is enhanced by its research collaborations and participation in clinical trials. Future opportunities include expanding its research portfolio and developing new diagnostic tools. Regulatory compliance and clinical validation are crucial for the success of these activities. Partnerships with universities and research institutions are essential for driving innovation and advancing scientific knowledge.